Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ascensia Diabetes Care And Senseonics Announced That Medicare Has Expanded Access To Eversense E3 CGM System, With Implementation Of Local Coverage Determinations To Access Implantable CGM For Basal-Only Patients, By First Three Medicare Contractors

Author: Benzinga Newsdesk | February 12, 2024 08:20am

Posted In: SENS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist